openPR Logo
Press release

Cerebrospinal Fluid Management Market Size Projected to Rise Lucratively during 2023

09-26-2017 08:36 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Cerebrospinal Fluid Management Market Size Projected to Rise

Transparency Market Research states that the global cerebrospinal fluid (CSF) management market will exhibit a healthy 5.5% CAGR over the period between 2015 and 2023, rising from a valuation of US$1,135.7 mn in 2014 to US$1,840.5 mn in 2023.

North America to Continue to Provide Most Lucrative Revenue Prospects

In terms of product type, the segment of CSF shunts dominated the market in 2014 and is expected to retain its leading position over the forecast period as well. From a geographical standpoint, the CSF management market in North America dominated in terms of revenue contribution to the global CSF management market in 2014. The region is also likely to retain its top spot in the global market over the report’s forecast period, chiefly owing to factors such as rising geriatric population and easy availability of technologically advanced products. However, the market in Asia Pacific is projected to gain the maximum traction over the report’s forecast period owing to the increased demand for minimally invasive surgeries and a thriving medical tourism industry in emerging countries.

View and Download TOC of Cerebrospinal Fluid (CSF) Management Market Research Report@ https://www.transparencymarketresearch.com/report-toc/2590

Rapid Pace of Development of Healthcare Infrastructure in Developing Economies to Drive Market

Factors such as the vast rise in the prevalence of brain and neurological disorders, rising geriatric population, a demographic that is highly susceptible to neurodegenerative diseases such as Alzheimer’s and Parkinson's, and the rising scope of minimally invasive surgeries are key to the future growth potential of the global CSF management market. The market is also expected to benefit vastly from increased funding by government and private organizations across emerging economies aimed at providing effective treatment to a rising patient pool of neurological conditions.

Moreover, the promising pace of development of healthcare infrastructure, rising disposable incomes and the subsequent rise in healthcare spending of the global population, and the easy availability of technologically advanced healthcare interventions across distant corners of the globe are also expected to present promising growth opportunities to the CSF management market. These factors will especially bear significant impact in regional markets such as Latin America and Asia Pacific with a number of high-growth potential emerging economies.

Request and Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2590

High Cost of Surgeries Could Affect Market Growth to Some Extent

The market could, however, bear the brunt of challenges such as the high cost of CSF management surgeries and issues concerning the potential of infections caused by the use of CSF shunts. These factors are projected to hinder the growth prospects of the global CSF management market to a certain extent over the report’s forecast period. Nevertheless, the increased rate of awareness and improvements across the healthcare infrastructure in emerging economies such as India, China, and Brazil could present promising growth opportunities for the market to survive the negative influences of the aforesaid challenges.

The highly competitive vendor landscape of the global cerebrospinal fluid (CSF) management market features several large and medium scale companies continuously involved in developments and innovations related to technology and applications, says a recent report by Transparency Market Research. The market is expected to witness a continued rise in development activities as companies focus on adopting better ways to effectively cater to the multidimensional and vast set of needs of the end users.

Some of the leading companies in the market are Medtronic plc, DePuy Synthes, Integra LifeSciences Holding Corporation, B. Braun Melsungen AG, Sophysa S.A., Möller Medical GmbH, BeckerSmith Medical, Inc., and Spiegelberg GmbH & Co. KG.

Buy Full Cerebrospinal Fluid (CSF) Management Market Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=2590<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cerebrospinal Fluid Management Market Size Projected to Rise Lucratively during 2023 here

News-ID: 739092 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for CSF

G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation. Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081 This report studies
Trends in Cerebrospinal Fluid (CSF) Management Market
The global cerebrospinal fluid management market is foreseen to experience a tremendous growth within the forecast period from 2015 to 2023. The organizations are carrying out mergers and acquisitions, regional expansion, strategic tie-ups, and new product launches, with a specific end goal to manage their position in the market. For example, in 2015, Codman Neuro (working unit of Johnson and Johnson Services, Inc.) presented a novel MRI-safe programmable valve with
Cerebrospinal Fluid (CSF) Management Market (Product - CSF Shunts and CSF Draina …
Albany, NY, 5th September : Recent research and the current scenario as well as future market potential of " Trend of Cerebrospinal Fluid (CSF) Management Market in Global Industry : Market Development, Analysis and Overview 2017 " globally. Hydrocephalus is defined as an abnormal increase in the amount of cerebrospinal fluid inside the cranial cavity accompanied with enlargement of cerebral ventricles, which frequently leads to intracranial pressure and skull enlargement. Get PDF
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes. The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on